Publications by authors named "M Salimova"
Context: Previous studies have shown that the prevalence of polycystic ovary syndrome (PCOS) may vary according to race/ethnicity, although a few studies have assessed women of different ethnicities who live in similar geographic and socioeconomic conditions.
Objective: To determine the prevalence of PCOS in an unselected multiethnic population of premenopausal women.
Design: A multicenter prospective cross-sectional study.
Article Synopsis
- The study explores the impact of cocaine use disorder (CUD) on gut and oral microbiota, revealing significant changes in microbiota composition.
- It highlights that CUD patients experience decreased microbial diversity and alterations in microbial populations, along with altered metabolic pathways and lower butyric acid levels.
- Following repetitive transcranial magnetic stimulation (rTMS) treatment, some microbiota levels and functions were restored, indicating potential benefits of rTMS in normalizing microbiota in CUD patients.
Abnormalities in gut microbiota diversity are considered important mechanisms in metabolic disorders in polycystic ovarian syndrome (PCOS). However, the data on the association of these disorders with the PCOS phenotype remain controversial. The objectives of this study were to estimate the alpha diversity of the gut microbiota of healthy women and PCOS patients depending on phenotype.
View Article and Find Full Text PDFAndrogen assessment is a key element for diagnosing polycystic ovary syndrome (PCOS), and defining a "normal" level of circulating androgens is critical for epidemiological studies. We determined the upper normal limits (UNLs) for androgens in a population-based group of premenopausal "healthy control" women, overall and by ethnicity (Caucasian and Asian), in the cross-sectional Eastern Siberia PCOS Epidemiology and Phenotype (ESPEP) Study (ClinicalTrials.gov ID: NCT05194384) conducted in 2016-2019.
View Article and Find Full Text PDFBackground: Cocaine use disorder (CUD) is a global health issue with no effective treatment. Repetitive Transcranial Magnetic Stimulation (rTMS) is a recently proposed therapy for CUD.
Methods: We conducted a single-center, randomised, sham-controlled, blinded, parallel-group research with patients randomly allocated to rTMS (15 Hz) or Sham group (1:1) using a computerised block randomisation process.